Evidence map›Paper›PMID 42340118›Full record

ReviewJournal of evaluation in clinical practice2026

Pricing Policy for Medical Oxygen and Potential Savings.

Thomas G Poder, Mamadou A Camara, Pierre-Alexandre Bouchard, François Lellouche

Abstract readReview
In one paragraph

Review in Journal of evaluation in clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas G PoderDépartement de médecine sociale et préventive, Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0001-7017-096X
Mamadou A CamaraCentre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal, Montréal, Canada.
Pierre-Alexandre BouchardCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada.
François LelloucheCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada.ORCID https://orcid.org/0000-0002-6402-7953

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedical oxygen is essential in modern medicine.

aimsThis study analyzes the pricing policies and costs of medical oxygen in Quebec, provides elements of international comparison, and explores the potential savings through the optimization of oxygen therapy practices. MATERIALS AND

methodsIt combines a narrative literature review, an analysis of administrative and financial documents, as well as administrative data obtained from representatives of the healthcare sector in Quebec.

resultsThe literature review highlights the challenges of producing, storing, and distributing medical oxygen, which have been accentuated by the COVID-19 pandemic. A very large disparity in pricing policies is also noted among healthcare systems, especially when cylinders are predominantly used. In Quebec, costs vary according to production methods, logistics, and contractual clauses. Optimizing oxygen therapy practices would allow significant savings, particularly by reducing oxygen consumption through various strategies. DISCUSSION: The study shows the complexity of managing medical oxygen costs, amplified by limited competition and rigid contractual clauses. International comparison highlights the importance of infrastructure, while optimizing oxygen therapy practices offers significant savings potential. To reduce costs, it is recommended to improve distribution management, adopt more flexible contractual clauses, and strengthen competition.

conclusionTo optimize medical oxygen use, actions to undertake from managers and clinicians are highlighted.

Indexed as

Costs and Cost AnalysisCost SavingsCOVID-19OxygenOxygen Inhalation TherapyHumansQuebecOxygencostmedical oxygenpricing policyQuebec

Identifiers

PMID42340118
PMCPMC13292069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.